ProCE Banner Activity

Single-Agent PARP Inhibitors in Advanced Prostate Cancer

Slideset Download
Download these slides from a live Webinar to review the most recent clinical data on single-agent PARP inhibitors in metastatic castration-resistant prostate cancer

Released: February 19, 2021

Expiration: February 18, 2022

Share

Faculty

Charles Ryan

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer TEXT Only

Faculty Disclosure

Primary Author

Charles Ryan, MD

Associate Clinical Professor
Department of Medicine Hematology/Oncology
University of California, San Francisco
San Francisco, California